128 Participants Needed

Transpulmonary Pressure-Guided Ventilation Weaning for Obesity-Related Respiratory Issues

ME
AW
Overseen ByAndrew Wilhelm, DO
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Mississippi Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will look at whether accounting for the amount of pressure generated by the chest wall and abdomen in a obese patient, using a measurement called transpulmonary pressure, can help shorten the amount of time patients spend on the ventilator. By decreasing the amount of time patients spend on the ventilator, they are less likely to develop complications such as infections, weakness or more procedures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is transpulmonary pressure-guided ventilation safe for humans?

Transpulmonary pressure-guided ventilation, which uses esophageal pressure monitoring, is considered minimally invasive and has been used to guide ventilation support in various conditions, including acute respiratory distress syndrome. It helps in adjusting ventilation settings to potentially reduce the risk of lung injury during mechanical ventilation.12345

How is transpulmonary pressure-guided PEEP different from other treatments for obesity-related respiratory issues?

Transpulmonary pressure-guided PEEP is unique because it uses esophageal pressure measurements to tailor the ventilation settings specifically for obese patients, potentially improving lung function and oxygen levels more effectively than traditional methods. This approach is particularly beneficial for patients with high pleural pressures, which are common in obesity, and aims to optimize mechanical ventilation by individualizing treatment.12367

What data supports the effectiveness of transpulmonary pressure-guided ventilation weaning for obesity-related respiratory issues?

Research suggests that using esophageal pressure to guide PEEP settings may help improve lung function in obese patients by better managing the pressure in the lungs, although more studies are needed to confirm its benefits specifically for obesity-related respiratory issues.12348

Are You a Good Fit for This Trial?

This trial is for obese patients (BMI ≥ 35.0 kg/m²) who have been on a ventilator for less than 48 hours due to respiratory failure. It's not suitable for those with esophageal or gastrointestinal issues, low platelet counts, neuromuscular diseases, difficult airways, life expectancy under 48 hours, prior chronic ventilation needs, severe neurological injuries or known pleural diseases.

Inclusion Criteria

I have been on a breathing machine for less than 2 days due to breathing failure.
My BMI is 35 or higher, classifying me as class II obese or higher.

Exclusion Criteria

I cannot have an esophageal balloon catheter due to certain health issues.
You have a disease that affects your muscles and nerves.
You have a known problem with your airway that makes it hard to breathe.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Transpulmonary pressure guided positive end expiratory pressure (PEEP) titration for ventilation and spontaneous breathing trials (SBT) to shorten the time to liberation from mechanical ventilation

4 weeks
Daily assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment, including mortality, ICU and hospital length of stay, and re-intubation rates

30 days

What Are the Treatments Tested in This Trial?

Interventions

  • standard positive end expiratory pressure
  • transpulmonary pressure guided positive end expiratory pressure
Trial Overview The study tests if using transpulmonary pressure to guide ventilation weaning in obese patients can reduce time spent on mechanical ventilation and prevent complications like infections and weakness compared to standard methods.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Transpulmonary pressure guided positive end expiratory pressureExperimental Treatment1 Intervention
Group II: Standard positive end expiratory pressureActive Control1 Intervention

transpulmonary pressure guided positive end expiratory pressure is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Transpulmonary Pressure Guided PEEP for:
🇪🇺
Approved in European Union as Transpulmonary Pressure Guided PEEP for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Mississippi Medical Center

Lead Sponsor

Trials
185
Recruited
200,000+

Published Research Related to This Trial

In a study of 105 patients on mechanical ventilation, obese individuals had significantly higher esophageal pressure (Pes) compared to non-obese individuals, indicating a greater risk of alveolar collapse due to high pleural pressure.
Applying a Pes-guided PEEP protocol in obese patients could lead to higher PEEP settings than standard empirical methods, suggesting that personalized PEEP adjustments may improve ventilator outcomes for this population.
Evaluation of Esophageal Pressures in Mechanically Ventilated Obese Patients.Thind, GS., Mireles-Cabodevila, E., Chatburn, RL., et al.[2023]
In a study of 29 obese patients with acute respiratory distress syndrome (ARDS), using esophageal manometry to guide positive end-expiratory pressure (PEEP) titration significantly increased PEEP from 12 to 20 cm H2O and decreased driving pressure from 15 to 13 cm H2O, indicating improved lung mechanics.
This method also led to improved oxygenation, as evidenced by a decrease in the required fraction of inspired oxygen (Fio2) from 0.8 to 0.6 and an increase in the oxygen saturation/Fio2 (S/F) ratio from 120 to 165, demonstrating the efficacy of transpulmonary pressure-guided ventilation in this patient population.
Retrospective Review of Transpulmonary Pressure Guided Positive End-Expiratory Pressure Titration for Mechanical Ventilation in Class II and III Obesity.Liou, J., Doherty, D., Gillin, T., et al.[2023]
A new method for measuring esophageal pressure using an air-filled catheter without a balloon has been developed, which is simple, inexpensive, and reproducible, making it easier to implement in intensive care units.
This method was validated against the traditional balloon catheter in both laboratory and clinical settings, showing high accuracy and reliability for monitoring transpulmonary pressure in mechanically ventilated patients.
Novel method of transpulmonary pressure measurement with an air-filled esophageal catheter.Massion, PB., Berg, J., Samalea Suarez, N., et al.[2021]

Citations

Evaluation of Esophageal Pressures in Mechanically Ventilated Obese Patients. [2023]
Retrospective Review of Transpulmonary Pressure Guided Positive End-Expiratory Pressure Titration for Mechanical Ventilation in Class II and III Obesity. [2023]
Novel method of transpulmonary pressure measurement with an air-filled esophageal catheter. [2021]
Brief report: leaking esophageal probe may lead to false ventilator settings when guiding positive end-expiratory pressure by transpulmonary pressure. [2021]
Use of Transpulmonary Pressure Monitoring in the Management of Extrapulmonary Pediatric Acute Respiratory Distress Syndrome With multi organ dysfunction syndrome (MODS): Are We Peepophobic? [2020]
Practical Aspects of Esophageal Pressure Monitoring in Patients with Acute Respiratory Distress Syndrome. [2023]
Transpulmonary Pressure-Guided Lung-Protective Ventilation Improves Pulmonary Mechanics and Oxygenation Among Obese Subjects on Mechanical Ventilation. [2023]
Effective Ventilation Strategies for Obese Patients Undergoing Bariatric Surgery: A Literature Review. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security